To explore the value of spectral CT in the diagnosis and treatment of gastric cancer
To explore the value of spectral CT in the diagnosis and treatment of gastric cancer: CT scan of the abdomen outside of standard treatment options
Study summary
Spectral CT was used to prospectively collect medical images and clinical data related to gastric cancer, evaluate the effect of image quality in the diagnosis of gastric cancer, and evaluate the application value in the accurate staging of gastric cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* (a)Patients with pathologically confirmed gastric cancer;
* (b) aged ≥ 18 years old;
* (c) have not received chemoradiotherapy or surgery.
Exclusion Criteria:
* (a)Combined with other primary tumors;
* (b) The image quality does not meet the diagnostic criteria;
* (c)Those who cannot tolerate CT examination.
Primary outcome measure(s)
Pathological TNM staging — 1 day Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.